| Upcoming IPOs | IPO Date | size |
|---|
SpaceX's Explosive IPO Could Turn These Early Investors Into Mega Winners: Report
Hedge fund D1 Capital Partners is reportedly poised to reap significant benefits from the upcoming public listing of Elon Musk's SpaceX.D1 Capital's stake in SpaceX could be worth approximately $20 billion if the rocket manufacturer achieves its anticipated $1.75 trillion valuation, reported the Financial Times. The hedge fund, managed by Dan Sundheim, was one of the early investors in SpaceX, taking a position in 2020 when the company was valued at around $36 billion.
Why a company goes public and how you sh...
Each week we discuss the current happenings of the IPO (Initial Public Offering) market to keep you updated on anything that may be coming u...
Why a company goes public and how you sh...
Each week we discuss the current happenings of the IPO (Initial Public Offering) market to keep you updated on anything that may be coming u...
Dissecting IPO markets for 2016.
Previously we discussed the health of the IPO market as it relates to the number of deals, proceeds, and performance. Today we dig a little...
Dissecting IPO markets for 2016.
Previously we discussed the health of the IPO market as it relates to the number of deals, proceeds, and performance. Today we dig a little...
Who should invest in IPO's?
IPO's, or initial public offerings can be a hot topic issue in the financial advisory / investment services industry. On one hand some of th...
Who should invest in IPO's?
IPO's, or initial public offerings can be a hot topic issue in the financial advisory / investment services industry. On one hand some of th...
IPO Update: BELLUS Health Announces Open...
Recently Priced Today saw the introduction of BELLUS Health (NASDAQ:BLU) that is priced at $7.10 a share with 9,859,155 shares. BELLUS Healt...
IPO Update: BELLUS Health Announces Open...
Recently Priced Today saw the introduction of BELLUS Health (NASDAQ:BLU) that is priced at $7.10 a share with 9,859,155 shares. BELLUS Healt...
How to go IPO (and buy shares of new com...
Brian Herman is Managing Director of Viewtrade Securities. He has worked in the securities and investment banking businesses since the 1990'...
How to go IPO (and buy shares of new com...
Brian Herman is Managing Director of Viewtrade Securities. He has worked in the securities and investment banking businesses since the 1990'...
A good start for 2016 IPO’s
The first IPO's of 2016 hit the market this week and both were biotech company's. Although 81% of all 2015 biotech IPO's trade below opening...
A good start for 2016 IPO’s
The first IPO's of 2016 hit the market this week and both were biotech company's. Although 81% of all 2015 biotech IPO's trade below opening...
